Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation

Human Immunology

Volumn 69, Issue 6, 2008, Pages 329-337

  Noël, Grégory ^a   Bruniquel, Denis ^a,b   DeGuibert, Sophie ^a,c   Birebent, Brigitte ^a,b   Grosset, Jean Marc ^b   Bernard, Marc ^c   Dauriac, Charlie ^c   Lamy de la Chapelle, Thierry ^c   Semana, Gilbert ^a,b   Brinster, Carine ^a,b  

^a Laboratoire d'Immuno Hématologie   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Acute graft versus host disease; Granulocyte colony stimulating factor; Regulatory T cells; Tolerance; Transplantation

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; INTERLEUKIN 2 RECEPTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DONOR; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; REGULATORY T LYMPHOCYTE; ADOPTIVE TRANSFER; CD4+ T LYMPHOCYTE; DRUG EFFECT; FEMALE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; STEM CELL MOBILIZATION; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 49249123066     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.04.008     Document Type: Article

References (28)

1. Horowitz M.M., Gale R.P., Sondel P.M., Goldman J.M., Kersey J., Kolb H.J., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75 (1990) 555
2. Martin P.J., Hansen J.A., Buckner C.D., Sanders J.E., Deeg H.J., Stewart P., et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66 (1985) 664
3. Ellison C.A., Fischer J.M., HayGlass K.T., and Gartner J.G. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. J Immunol 161 (1998) 631
4. Krenger W., Snyder K.M., Byon J.C.H., Falzarano G., and Ferrara J.L.M. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 155 (1995) 585
5. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 7 (2007) 340
6. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., and Anasetti C. Granulocyte colony-stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95 (2000) 2484
7. Mielcarek M., Graf L., Johnson G., and Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: A mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92 (1998) 215
8. Sloand E.M., Kim S., Maciejewski J.P., Van Rhee F., Chaudhuri A., Barrett J., et al. Pharmalogic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95 (2000) 2269
9. Piccirillo C.A., and Shevach E.M. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167 (2001) 1137
10. Thornton A.M., Piccirillo C.A., and Shevach E.M. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 34 (2004) 366
11. Cohen J.L., Trenado A., Vasey D., Klatzmann D., and Salomon B.L. CD4(+)CD25(+) immunoregulatory T cells: New therapeutics for graft-versus-host disease. J Exp Med 196 (2002) 401
12. Taylor P.A., Lees C.J., and Blazar B.R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99 (2002) 3493
13. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C.G., Strober S., et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9 (2003) 1144
14. Trenado A., Charlotte F., Fisson S., Yagello M., Klatzmann D., Salomon B.L., et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112 (2003) 1688
15. Hoffmann P., Ermann J., Edinger M., Fathman C.G., and Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196 (2002) 389
16. Trenado A., Sudres M., Tang Q., Maury S., Charlotte F., Gregoire S., et al. Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J Immunol 176 (2006) 1266
17. Rutella S., Zavala F., Danese S., Kared H., and Leone G. Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance. J Immunol 175 (2005) 7085
18. Baecher-Allan C., Brown J.A., Freeman G.J., and Hafler D.A. CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 167 (2001) 1245
19. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203 (2006) 1701
20. Rutella S., Rumi C., Pierelli L., Morosetti R., Sica S., Bonanno G., et al. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp Hematol 28 (2000) 612
21. Stanzani M., Martins S.L.R., Saliba R.M., St John L.S., Bryan S., Couriel D., et al. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood 103 (2004) 1140
22. Rezvani K., Mielke S., Ahmadzadeh M., Kilical Y., Savani B.N., Zeilah J., et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108 (2006) 1291
23. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112 (2003) 1437
24. Ziegler S.F. FOXP3: Not just for regulatory T cells anymore. Eur J Immunol 37 (2007) 21
25. Nguyen V.H., Shashidhar S., Chang D.S., Ho L., Kambham N., Bachmann M., et al. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111 (2008) 945
26. Trenado A., Fisson S., Braunberger E., Klatzmann D., Salomon B.L., and Cohen J.L. Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation. Transplantation 77 1 Suppl (2004) S32
27. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., and Roncarolo M.G. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177 (2006) 8338
28. Battaglia M., Stabilini A., and Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105 (2005) 4743